Jan 28, 2025, 17:20
Melanoma clinical trial ME17 is officially open for enrollment in Canada – Canadian Cancer Trials Group
Canadian Cancer Trials Group shared a post on LinkedIn:
“Melanoma clinical trial ME17 is officially open for enrollment in Canada. The study will compare immunotherapy alone with adding FMT treatment to the immunotherapy to improve outcomes.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 28, 2025, 17:18
Jan 28, 2025, 17:02
Jan 28, 2025, 16:36
Jan 28, 2025, 16:22